Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244554 · ClinicalTrials.gov registry record · NA
Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal
A NA study, sponsored by Cutera.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02244554 is a NA study that has completed, run by Cutera. The registered enrollment target is 10 participants.
The verdict
NCT02244554, a NA study, has completed, sponsored by Cutera.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of laser tattoo removal with picosecond pulse durations as compared to treatment with nanosecond pulse durations using a single novel Q-Switched (QS) Nd:YAG laser.
Interventions
- DEVICE enLighten Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02244554
The ClinicalTrials.gov registry entry for NCT02244554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which enLighten Laser is the first listed.
NCT02244554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02244554 about?
NCT02244554 is a clinical study titled "Comparison Study of Picosecond and Nanosecond Pulse Durations Using a Q-switched Nd:YAG Laser for Tattoo Removal". The purpose of this study is to evaluate the safety and efficacy of laser tattoo removal with picosecond pulse durations as compared to treatment with nanosecond pulse durations using a single novel Q-Switched (QS) Nd:YAG laser.
What is the current status of trial NCT02244554?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02244554?
The interventions under investigation include: enLighten Laser (DEVICE).
Who is sponsoring clinical trial NCT02244554?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.